National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

nedaplatin
A second-generation cisplatin analogue with antineoplastic activity. Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucelophillic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis and cell death. This agent appears to be less nephrotoxic and neurotoxic compared to both cisplatin and carboplatin. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Chemical structure name:platinum, diammine(hydroxy-kappaO)acetato(2-)-kappaO)-, (SP-4-3)-



Previous:Natrecor, natural human interferon alpha OPC-18, Navelbine, NB1011, Nebcin
Next:nelarabine, nelfinavir mesylate, Neo-Oestronol I, Neogest, Neoquin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov